High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis

por Khwaja, Jahanzaib, Bomsztyk, Joshua, Mahmood, Shameem, Wisniowski, Brendan, Shah, Raakhee, Tailor, Anish, Yong, Kwee, Popat, Rakesh, Rabin, Neil, Kyriakou, Charalampia, Sive, Jonathan, Esposti, Simona Degli, Larkin, Daniel F. P., Worthington, Sarah, Hart, Alyse, Dowling, Emma, Correia, Nuno, Bygrave, Ceri, Rydzewski, Andrzej, Jamroziak, Krzysztof, Wechalekar, Ashutosh D.
Publicado 2022